Advertisement

Topics

Latest "The Research Council of Norway" News Stories

02:30 EST 15th December 2018 | BioPortfolio

Here are the most relevant search results for "The Research Council of Norway" found in our extensive news archives from over 250 global news sources.

More Information about The Research Council of Norway on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about The Research Council of Norway for you to read. Along with our medical data and news we also list The Research Council of Norway Clinical Trials, which are updated daily. BioPortfolio also has a large database of The Research Council of Norway Companies for you to search.

Showing "Research Council Norway" News Articles 1–25 of 29,000+

Saturday 15th December 2018

Twist Bioscience Corp Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 27082018] Prices from USD $250

SummaryTwist Bioscience Corp Twist Bioscience is a DNA specializing and development company that develops DNA products ad DNA synthesis process. The company provides products includes DNA pools for gRNA cloning such as unamplified oligo pools, cloningready oligo pools; protein scanning single variant libraries, clonal perfect genes and nonclonal fragments, among others. The company operates in the...


Friday 14th December 2018

Novanta Inc NOVT Medical Equipment Deals and Alliances Profile [Report Updated: 07092018] Prices from USD $250

SummaryNovanta Inc Novanta, formerly GSI Group Inc is a medical device company that manufactures and markets precision photonics, motion control components and subsystems. The company provides laser products, medical technologies, and precision motion products. It offers laser sources and beam delivery technologies for electronics, industrial, medical, and scientific applications. Novanta 's techn...

Open Access--or Open Science?

Open Access mandates in Europe raise the question if the priority is to reduce publishing costs, or the overdue conversion to Open Science communication. At risk are not only high-quality journals, but also community institutions and international research collaboration.


Avery Dennison Corporation AVY Medical Equipment Deals and Alliances Profile [Report Updated: 06122018] Prices from USD $250

SummaryAvery Dennison Corporation Avery Dennison is a labeling and packaging materials and solutions provider. The company produces pressuresensitive materials, tags, labels, tickets, and other converted products. It also manufactures and sells fasteners, tickets, tags, RFID inlays and tags, and imprinting equipment and related services. It offers products under the brands such as Avery Dennison, ...

[Articles] A protracted mumps outbreak in Western Australia despite high vaccine coverage: a population-based surveillance study

The number of mumps outbreaks reported in recent years among highly vaccinated populations, including Indigenous populations, has been growing. More widespread and pre-emptive use of the third dose of measles, mumps, and rubella vaccine might be required to control and prevent future outbreaks in high-risk populations. Research should explore the benefit of increasing the intervals between vaccine...

Sorrento Therapeutics Inc SRNE Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 23102018] Prices from USD $250

SummarySorrento Therapeutics Inc STI, formerly QuikByte Software Inc, is a cancer therapeutic service provider. The company offers CD38 CART, lidocaine topical system, resiniferatoxin. Its product pipeline includes CD38 CART, CEA CART, CD38 ADC and seprehvir. STI provides treatment for multiple myeloma, metastatic liver tumors and solid tumors. The company offers therapies for immune oncology, pai...

Torn from the headlines: role of public awareness and bench- to-bedside research in prevention and treatment of Acanthamoeba keratitis

Kindred Healthcare Inc KND Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 09112018] Prices from USD $250

SummaryKindred Healthcare Inc Kindred Healthcare is a healthcare services provider with focus on postacute care services. The company through its subsidiaries offers home health, hospice and community care services to patients in homes, nursing centers, and other residential settings. It operates transitional care TC hospitals, inpatient rehabilitation hospitals IRFs, community care business, assi...

Celltrion Healthcare Co Ltd 091990 Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 23102018] Prices from USD $250

SummaryCelltrion Healthcare Co Ltd Celltrion is engaged in distributing, marketing and selling of biosimilar and biological medicines. Its products include Remsima and Truxima. Remsima is a biosimilar monoclonal antibody medication used for autoimmune diseases, including Crohn's disease CD, ulcerative colitis, rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis and plaque psoriasis. ...

Research offers hope for patients with serious bone marrow cancer

Hope has emerged for patients with a serious type of bone marrow cancer as new research into a therapeutic drug has revealed improved outcomes and survival rates.

Experimental HIV vaccine strategy works in non-human primates, research shows

For more than 20 years, scientists at Scripps Research have chipped away at the challenges of designing an HIV vaccine. Now new research, published in Immunity, shows that their experimental vaccine strategy works in non-human primates.

Breast cancer protection from pregnancy begins many decades later, study finds

In general, women who have had children have a lower risk of breast cancer compared to women who have never given birth. However, new research has found that moms don't experience this breast cancer protection until many years later and may face elevated risk for more than 20 years after their last pregnancy.

John Laing Group (JLG) - Delivering against guidance

Edison Investment Research - Financials - John Laing Group : John Laing Group’s (JLG’s) pre-close update confirms the strong level of activity in the business in FY18. JLG will provide guidance on the level of realisations and investment commitments expected for FY19 at its results (due March) but we believe the outlook for next year and beyond appears encouraging based on the investme...

GB Group (158355634GBG) - Location, location, location

Edison Investment Research - Technology - GB Group: GB Group’s Loqate division was the focus of yesterday’s capital markets day. Presenters highlighted the need for accurate address data as a prerequisite for many business processes, including e-commerce, insurance and invoicing. Loqate’s ability to provide the “golden record” in a simple, fast and consistent way give...

Manx Telecom (158355634MANX) - Worth listening out for clearSound

Edison Investment Research - Technology - Manx Telecom: In September, Manx Telecom (MT) subsidiary Goshawk announced the launch of clearSound (MTcS), an innovative mobile phone service for people with hearing needs. Following positive feedback from test groups, MT has signed a deal with BT/EE to launch the Goshawk proposition on their UK networks and it intends invest £10m on the launch over ...

STAT Plus: The #biotech team talks with Cecile Janssens, a research professor of epidemiology at Emory University, and asks what is a polygenic risk score and how good is it at predicting disease? https://buff.ly/2LkiLva 

STAT Plus: The #biotech team talks with Cecile Janssens, a research professor of epidemiology at Emory University, and asks what is a polygenic risk score and how good is it at predicting disease? https://buff.ly/2LkiLva 

Research model relates variations in #DNA and gene activity to the risk of brain disorders: http://ow.ly/neer30mZrGK 

Research model relates variations in #DNA and gene activity to the risk of brain disorders: http://ow.ly/neer30mZrGK 

Misinformation is the only poison: the end of the Seralini Affair? (reposted from GMOinfo.eu)

By Beat Späth, Director for Agricultural Biotechnology at EuropaBio ( Reposting of this original)“Do you remember? These spectacular images of rats with invasive cancers (…). Exhibited on television. Broadcast in film, book, resounding articles. (…) But do you know that on December 10, the journal Toxicology Sciences published o

Laboratoires Thea SA Strategic SWOT Analysis Review [Report Updated: 31102018] Prices from USD $125

Laboratoires Thea SA Strategic SWOT Analysis Review provides a comprehensive insight into the company's history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company's key employees, key competitors and major products and services.This uptotheminute company report will help you to formulate strategies to drive your busines...

Chemical Biologists Unearth Cause of Rare Brain Disorder

NewsResearchers have keyed into the biological mishap that causes stunted brain growth and muscle movement failure.

Informatica Named as a Leader in Gartner's Magic Quadrant for Master Data Management Solutions ...

REDWOOD CITY, Calif., Dec. 14, 2018 /PRNewswire/ -- Informatica, the enterprise cloud data management leader, today announced that Gartner, Inc., a leading IT research and Read more...

Sonora Quest Labs Taps BaseHealth to Leverage Lab Data to Reveal Patient Health Risks

In its first deployment of the new platform, BaseHealth is partnering with Sonora Quest Laboratories, Arizona’s leading provider of diagnostic testing and information services. BaseHealth’s platform combines laboratory data with insurance claims data, published clinical research, and other data sources then apply machine learning to prospectively identify patient health risks and suggest ap...

University of North Carolina System names A. Wesley Burks, M.D. CEO of UNC Health Care and UNC-Chapel Hill Medical School Dean

Dr. Burks tapped to lead growth efforts in education, research, and clinical care for North Carolina’s health system Dr. A. Wesley Burks, who has served as executive dean for the UNC School of Medicine and as a member of UNC Health Care’s senior leadership team, has been named CEO of UNC Health Care, Dean of the UNC School of Medicine, and Vice Cha...

Non-traumatic spinal cord injury in Norway 2012–2016: analysis from a national registry and comparison with traumatic spinal cord injury

Applied Genetic Technologies Corp AGTC Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 06122018] Prices from USD $250

SummaryApplied Genetic Technologies Corp AGTC is a pharmaceutical company that provides development of eye disease cures. The company develops treatments for patients that have diseases caused by broken genes. It offers products such as xlinked retinoschisis, achromatopsia, xlinked retinitis pigmentosa, alpha1 antitrypsin deficiency and macular degeneration, among others. AGTC's achromatopsia prov...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks